What treatments are effective for a refractory migraine with normal CT and MRI findings?

Treatment for Refractory Migraine with Normal Imaging

For migraines that fail typical medications with normal CT/MRI, use CGRP antagonists (gepants: rimegepant, ubrogepant, or zavegepant) or dihydroergotamine as next-line therapy, and if these fail, consider lasmiditan as a final pharmacologic option before exploring preventive medications and non-pharmacologic interventions. 1

Systematic Approach to Treatment-Resistant Migraine

Step 1: Verify Adequate Dosing of Standard Therapies

Before declaring treatment failure, confirm the patient has tried:

• NSAIDs at maximum doses (ibuprofen 800mg, naproxen 550mg) 1
• Combination therapy: Triptan + NSAID or acetaminophen (this is more effective than either alone) 1
• Multiple different triptans - failure of one triptan doesn't predict failure of others within the class (try almotriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, or zolmitriptan) 1
• Early treatment timing - triptans work best when taken at headache onset while pain is still mild 2

Step 2: Rule Out Medication Overuse Headache

This is a critical pitfall. If the patient uses:

• NSAIDs ≥15 days/month
• Triptans ≥10 days/month

They likely have medication overuse headache, which causes treatment resistance. This must be addressed first through medication withdrawal before other treatments will work effectively. 1

Step 3: Next-Line Acute Treatments

CGRP Antagonists (Gepants) - Preferred Option:

• Rimegepant, ubrogepant, or zavegepant 1
• Key advantage: Low risk of medication overuse headache compared to triptans 3
• Use when combination triptan + NSAID therapy fails or is contraindicated 1

Dihydroergotamine (DHE):

• Alternative option with similar efficacy profile 1
• Available as nasal spray or injection 4
• May cause more nausea than triptans 1

Lasmiditan (Ditan):

• Reserve as last-line acute treatment when all other options fail 1
• Critical warning: Causes temporary driving impairment - patients cannot drive for 8 hours after use 2
• This limitation significantly restricts practical use

Step 4: Consider Preventive Therapy

If acute treatments repeatedly fail or migraines occur frequently (≥4 days/month), preventive medications are essential: 1

First-line preventive options include:

• CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) - migraine-specific with superior tolerability 3, 5
• Topiramate 6, 5
• Propranolol or timolol 6
• Amitriptyline 6
• OnabotulinumtoxinA - specifically for chronic migraine (≥15 headache days/month), NOT episodic migraine 7

Step 5: Non-Pharmacologic Interventions

These should be integrated alongside medication:

• Aerobic exercise (moderate to intense, regular) 1, 7
• Physical therapy 7
• Stress management with relaxation techniques or mindfulness 1
• Sleep optimization (consistent schedule, adequate duration) 1
• Hydration and regular meals 1

Step 6: Address Comorbidities

Refractory migraine patients have significantly higher rates of:

• Psychiatric conditions (anxiety, depression, bipolar disorder) - treat these aggressively 8
• Temporomandibular joint disorders 8
• Trigger points 8
• Thyroid disorders 8

Proper treatment of these comorbidities may help overcome treatment resistance. 8

Critical Pitfalls to Avoid

1. Never use opioids or butalbital for migraine treatment - they worsen outcomes and increase medication overuse headache risk 1

2. Don't assume all triptans are equivalent - individual response varies significantly; trial multiple agents before declaring class failure 1

3. Consider non-oral routes if nausea/vomiting is prominent - subcutaneous sumatriptan, nasal sprays, or suppositories with antiemetics 1, 2

4. Screen for pregnancy/breastfeeding - many treatments have restrictions in these populations 1

When Standard Approaches Fail

For truly refractory cases after exhausting the above:

• Multidisciplinary headache clinic referral is essential 9, 5
• Consider neuromodulation devices (vagal nerve stimulation, occipital nerve stimulation) 10
• Combination preventive therapy may be needed 3, 5
• Recognize this may require ongoing n-of-1 treatment trials 9

The normal CT/MRI confirms this is primary migraine, not secondary headache, allowing confident escalation through these treatment tiers without concern for missing structural pathology.